The $1000 Genome Revolution

This luncheon presentation will feature expert opinions on the impact of the genomic revolution, and the implications of low-cost genetic testing. Speakers include Nancy Kelley, executive director of the New York Genome Center, David Darst, biotechnology analyst for OrbiMed, and David Ferreiro, executive director and senior life science analyst for Oppenheimer. Register here.